Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade
- Status
- COMPLETED
- Phase
- PHASE1
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
- Status
- COMPLETED
- Phase
- PHASE1
VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
- Status
- COMPLETED
- Phase
- PHASE3
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2